Global Cord Blood Corporation (CORBF)
OTCMKTS · Delayed Price · Currency is USD
0.7000
-0.0500 (-6.67%)
Oct 16, 2025, 11:18 AM EDT
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $93.74 million as of October 17, 2025. Its market cap has decreased by -62.16% in one year.
Market Cap
93.74M
Enterprise Value
n/a
Revenue
196.10M
Ranking
n/a
PE Ratio
1.08
Stock Price
$0.70
Market Cap Chart
Since July 1, 2009, Global Cord Blood's market cap has decreased from 968.15M to 93.74M, a decrease of -90.32%. That is a compound annual growth rate of -13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 93.74M | -53.33% |
| Dec 31, 2024 | 200.87M | 22.95% |
| Dec 29, 2023 | 163.38M | -67.92% |
| Dec 31, 2021 | 509.30M | 12.94% |
| Dec 31, 2020 | 450.95M | -25.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 671.98M |
| Elite Pharmaceuticals | 660.06M |
| Veradigm | 517.28M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 336.10M |
| Nika Pharmaceuticals | 333.67M |
| Silence Therapeutics | 307.02M |
| American Oncology Network | 277.57M |